Medicine

A new method combines synthetic biology with artificial intelligence more

Liver cells age differently depending on where they are in the organ more

A fully automated method significantly increases diagnostic accuracy more

In mice reprogramming of energy metabolism restores cardiac function after infarction more

Liraglutide benefits brain activity in people with obesity more

Special shapes can release active substances in a controlled manner more

Resarchers have found new possibilities for targeting cancer genes’ RNA with nature-inspired compounds more

New approaches for treating hypertension could focus on the interplay between mental and physical health more

The brain releases the hormone corticosterone after short fasting that boosts autophagy more

Scientists decipher a mechanism that may help prevent the formation of blood clots more

Interview with Johanna Rinceanu and Randall Stephenson, senior researchers at the Department of Criminal Law at the Max Planck Institute for the Study of Crime, Security and Law in Freiburg, on what medical diagnosis and modern-day internet regulation have in common more

Many publications by Max Planck scientists in 2022 were of great social relevance or met with a great media response. We have selected 12 articles to present you with an overview of some noteworthy research of the year more

Julia Zimmermann talks about the foundation of the company terraplasma GmbH more

People with autism often have outstanding skills, which can be enriching for businesses more

Admittedly, the research subject isn’t particularly appetizing: Strongyloides stercoralis – small parasitic worms that live in their host’s intestines and have the potential to cause severe problems. Nevertheless, Adrian Streit from the Max Planck Institute for Developmental Biology in Tübingen is fascinated by this threadworm. It has a unique life cycle, and to this day, no one really understands why more

Representative survey in Germany, the UK, and the US more

Reduced FoxO3 activity reprograms connective tissue cells, triggering the disease more

FKBP51-protein inhibitors could be used for treating diabetes more

Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension more

Scientists are developing cell-like lipid vesicles which can be populated with natural cell proteins more